Comments on: Three Things I Learned at the FDA Social Media Hearings and Three I Wish I Had http://www.doseofdigital.com/2009/11/three-things-i-learned-at-the-fda-social-media-hearings-and-three-i-wish-i-had/ Improving Healthcare Through Digital Technology -- Effectively using digital technology and social media in pharma and healthcare Tue, 24 Jan 2012 00:11:00 +0000 hourly 1 http://wordpress.org/?v=3.3.1 By: Jonathan Richman http://www.doseofdigital.com/2009/11/three-things-i-learned-at-the-fda-social-media-hearings-and-three-i-wish-i-had/#comment-3245 Jonathan Richman Sun, 22 Nov 2009 01:53:10 +0000 http://www.doseofdigital.com/?p=1743#comment-3245 Thanks, Ed. Be sure to check out my post called "166 Adverse Events Equals One Red Herring" to get a feel for how many reportable events a day the pharma industry might face using a few bits of data: http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-read-herring/ Thanks, Ed. Be sure to check out my post called “166 Adverse Events Equals One Red Herring” to get a feel for how many reportable events a day the pharma industry might face using a few bits of data: http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-read-herring/

]]> By: Jonathan Richman http://www.doseofdigital.com/2009/11/three-things-i-learned-at-the-fda-social-media-hearings-and-three-i-wish-i-had/#comment-9277 Jonathan Richman Sun, 22 Nov 2009 01:53:00 +0000 http://www.doseofdigital.com/?p=1743#comment-9277 Thanks, Ed. Be sure to check out my post called "166 Adverse Events Equals One Red Herring" to get a feel for how many reportable events a day the pharma industry might face using a few bits of data: http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-read-herring/ Thanks, Ed. Be sure to check out my post called “166 Adverse Events Equals One Red Herring” to get a feel for how many reportable events a day the pharma industry might face using a few bits of data: http://www.doseofdigital.com/2009/11/166-reportable-adverse-events-equals-one-read-herring/

]]> By: Why Pharma Needs Social Media | PRforPharma http://www.doseofdigital.com/2009/11/three-things-i-learned-at-the-fda-social-media-hearings-and-three-i-wish-i-had/#comment-3230 Why Pharma Needs Social Media | PRforPharma Fri, 20 Nov 2009 18:06:47 +0000 http://www.doseofdigital.com/?p=1743#comment-3230 [...] We even formed a united front and marched to capital hill to tell the FDA why it should issue guidance on how pharma companies are permitted to engage in social media. [...] [...] We even formed a united front and marched to capital hill to tell the FDA why it should issue guidance on how pharma companies are permitted to engage in social media. [...]

]]> By: Ed Purkis http://www.doseofdigital.com/2009/11/three-things-i-learned-at-the-fda-social-media-hearings-and-three-i-wish-i-had/#comment-3224 Ed Purkis Fri, 20 Nov 2009 14:40:39 +0000 http://www.doseofdigital.com/?p=1743#comment-3224 More learnings for us in the UK – thanks for sharing the slides Jon. Particularly interested to see only 1 in 500 posts qualifies as a ‘reportable adverse event’. Legally, it’s always going to be a barrier to pharma communicating online in the UK, although this kind of thing definitely helps to calm the nerves of our (understandably) cautious pharma colleagues and feel more comfortable about other forms of online engagement. Look forward to seeing how things develop. Keep us updated – the blog is great! Ed www.blog.virgohealth.com .-= Ed Purkis´s last blog ..<a href="http://blog.virgohealth.com/2009/11/pharma-online-are-we-wanted/" rel="nofollow">Pharma online: Are we wanted?</a> =-. More learnings for us in the UK – thanks for sharing the slides Jon. Particularly interested to see only 1 in 500 posts qualifies as a ‘reportable adverse event’. Legally, it’s always going to be a barrier to pharma communicating online in the UK, although this kind of thing definitely helps to calm the nerves of our (understandably) cautious pharma colleagues and feel more comfortable about other forms of online engagement.

Look forward to seeing how things develop. Keep us updated – the blog is great!

Ed

http://www.blog.virgohealth.com
.-= Ed Purkis´s last blog ..Pharma online: Are we wanted? =-.

]]> By: Ed Purkis http://www.doseofdigital.com/2009/11/three-things-i-learned-at-the-fda-social-media-hearings-and-three-i-wish-i-had/#comment-9276 Ed Purkis Fri, 20 Nov 2009 14:40:00 +0000 http://www.doseofdigital.com/?p=1743#comment-9276 More learnings for us in the UK – thanks for sharing the slides Jon. Particularly interested to see only 1 in 500 posts qualifies as a ‘reportable adverse event’. Legally, it’s always going to be a barrier to pharma communicating online in the UK, although this kind of thing definitely helps to calm the nerves of our (understandably) cautious pharma colleagues and feel more comfortable about other forms of online engagement. Look forward to seeing how things develop. Keep us updated – the blog is great! Ed www.blog.virgohealth.com .-= Ed Purkis´s last blog ..<a href="http://blog.virgohealth.com/2009/11/pharma-online-are-we-wanted/" rel="nofollow">Pharma online: Are we wanted?</a> =-. More learnings for us in the UK – thanks for sharing the slides Jon. Particularly interested to see only 1 in 500 posts qualifies as a ‘reportable adverse event’. Legally, it’s always going to be a barrier to pharma communicating online in the UK, although this kind of thing definitely helps to calm the nerves of our (understandably) cautious pharma colleagues and feel more comfortable about other forms of online engagement.

Look forward to seeing how things develop. Keep us updated – the blog is great!

Ed

http://www.blog.virgohealth.com
.-= Ed Purkis´s last blog ..Pharma online: Are we wanted? =-.

]]> By: Lisa Emrich http://www.doseofdigital.com/2009/11/three-things-i-learned-at-the-fda-social-media-hearings-and-three-i-wish-i-had/#comment-3195 Lisa Emrich Wed, 18 Nov 2009 23:24:35 +0000 http://www.doseofdigital.com/?p=1743#comment-3195 I agree that it could be must more user-friendly. Most folks aren't going to go through the amount of pages I did just to see what information (in total) was included on the pages. It should be rewritten and redesigned to appeal to a wide range of individuals. There is definitely much room for improvement. In the meantime, though, we should do what we can to talk about the benefits of reporting serious adverse events (and confusing labeling, etc) for the betterment of health in general and not expect that pharma companies or our doctors are the only ones capable and expected to speak up. .-= Lisa Emrich´s last blog ..<a href="http://feedproxy.google.com/~r/BrassAndIvory/~3/aALSH61QbdA/patients-for-moment-at-chronicbabe.html" rel="nofollow">Patients for a Moment at ChronicBabe</a> =-. I agree that it could be must more user-friendly. Most folks aren’t going to go through the amount of pages I did just to see what information (in total) was included on the pages. It should be rewritten and redesigned to appeal to a wide range of individuals. There is definitely much room for improvement.

In the meantime, though, we should do what we can to talk about the benefits of reporting serious adverse events (and confusing labeling, etc) for the betterment of health in general and not expect that pharma companies or our doctors are the only ones capable and expected to speak up.
.-= Lisa Emrich´s last blog ..Patients for a Moment at ChronicBabe =-.

]]> By: Lisa Emrich http://www.doseofdigital.com/2009/11/three-things-i-learned-at-the-fda-social-media-hearings-and-three-i-wish-i-had/#comment-9275 Lisa Emrich Wed, 18 Nov 2009 23:24:00 +0000 http://www.doseofdigital.com/?p=1743#comment-9275 I agree that it could be must more user-friendly. Most folks aren't going to go through the amount of pages I did just to see what information (in total) was included on the pages. It should be rewritten and redesigned to appeal to a wide range of individuals. There is definitely much room for improvement. In the meantime, though, we should do what we can to talk about the benefits of reporting serious adverse events (and confusing labeling, etc) for the betterment of health in general and not expect that pharma companies or our doctors are the only ones capable and expected to speak up. .-= Lisa Emrich´s last blog ..<a href="http://feedproxy.google.com/~r/BrassAndIvory/~3/aALSH61QbdA/patients-for-moment-at-chronicbabe.html" rel="nofollow">Patients for a Moment at ChronicBabe</a> =-. I agree that it could be must more user-friendly. Most folks aren’t going to go through the amount of pages I did just to see what information (in total) was included on the pages. It should be rewritten and redesigned to appeal to a wide range of individuals. There is definitely much room for improvement.

In the meantime, though, we should do what we can to talk about the benefits of reporting serious adverse events (and confusing labeling, etc) for the betterment of health in general and not expect that pharma companies or our doctors are the only ones capable and expected to speak up.
.-= Lisa Emrich´s last blog ..Patients for a Moment at ChronicBabe =-.

]]>